Scientific Publications

Transvaginal versus transabdominal ultrasound guidance for embryo
transfer in donor oocyte recipients: a randomized clinical trial

Bodri D, Colodrón M, García D, Obradors A, Vernaeve V, Coll O.

Fertil Steril. 2011 Jun;95(7):2263-2268.e1. Epub 2011 Apr 2.

Blastocyst culture is associated with an elevated incidence of monozygotic twinning after single embryo transfer

Kawachiya S, Bodri D, Shimada N, Kato K, Takehara Y, Kato O.

Fertil Steril. 2011 May;95(6):2140-2. Epub 2011 Jan 7.

Chronic viral infections and invasive procedures: risk of vertical
transmission and current recommendations

López M, Coll O.

Fetal Diagn Ther. 2010 Jul;28(1):1-8. Epub 2010 Jun 19

Gonadotropin-releasing hormone agonists versus
antagonists for controlled ovarian hyperstimulation in
oocyte donors: a systematic review and meta-analysis

Bodri D, Sunkara SK, Coomarasamy A.

Fertil Steril. 2011 Jan;95(1):164-9. Epub 2010 Aug 4.

Racial disparity in oocyte donation outcome: a multiethnic, matched cohort study.

Bodri D, Guillén JJ, López M, Vernaeve V, Coll O.

Hum Reprod. 2010 Feb;25(2):436-42. Epub 2009 Nov 24.

Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study.

Bodri D, Guillén JJ, Trullenque M, Schwenn K, Esteve C, Coll O.

Fertil Steril. 2010 May 1;93(7):2418-20. Epub 2009 Oct 2.

Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial.

Galindo A, Bodri D, Guillén JJ, Colodrón M, Vernaeve V, Coll O.

Gynecol Endocrinol. 2009 Jan;25(1):60-6.

Poor outcome in oocyte donation after elective transfer of a single cleavage-stage embryo in Turner syndrome patients.

Bodri D, Guillén JJ, Schwenn K, Casadesus S, Vidal R, Coll O.

Fertil Steril. 2009 Apr;91(4 Suppl):1489-92.

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.

Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.

Fertil Steril. 2009 Feb;91(2):365-71.

Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women.

López S, Coll O, Durban M, Hernàndez S, Vidal R, Suy A, Morén C, Casademont J, Cardellach F, Mataró D, Miró O, Garrabou G.

Antivir Ther. 2008;13(6):833-8.

Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles.

Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll O.

Reprod Biomed Online. 2008 Aug;17(2):237-43.

Fertility choices and management for HIV-positive women.

Coll O, Lopez M, Hernandez S.

Curr Opin HIV AIDS. 2008 Mar;3(2):186-92.

Le diagostic préimplantatoire (DPI) actuellement en Espagne.

Polo A, Vidal R, Bodri D, Coll O.

La lettre du Gynécologue 2008; 335:25-27 – Not indexed in PubMed

Prognostic factors in oocyte donation: an analysis through egg-sharing recipient pairs showing a discordant outcome.

Bodri D, Colodron M, Vidal R, Galindo A, Durban M, Coll O.

Fertil Steril. 2007 Dec;88(6):1548-53.

Endometrial receptivity after oocyte donation in recipients with a history of chemotherapy and/or radiotherapy.

Vernaeve V, Bodri D, Colodrón M, Vidal R, Durbán M, Coll O.

Hum Reprod. 2007 Nov;22(11):2863-7.

Fertility assessment in non-infertile HIV-infected women and their partners.

Coll O, López M, Vidal R, Figueras F, Suy A, Hernández S, Loncà M, Palacio M, Martínez E, Vernaeve V.

Reprod Biomed Online. 2007 Apr;14(4):488-94.

Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial.

Bodri D, Vernaeve V, Guillén JJ, Vidal R, Figueras F, Coll O.

Hum Reprod. 2006 Sep;21(9):2246-51.

How successful is repeat testicular sperm extraction in patients with azoospermia?

Vernaeve V, Verheyen G, Goossens A, Van Steirteghem A, Devroey P, Tournaye H.

Hum Reprod. 2006 Jun;21(6):1551-4.

Oocyte donation in patients with Turner’s syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy.

Bodri D, Vernaeve V, Figueras F, Vidal R, Guillén JJ, Coll O.

Hum Reprod. 2006 Mar;21(3):829-32.:

Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART.

Coll O, Suy A, Figueras F, Vernaeve V, Martínez E, Mataró D, Durban M, Lonca M, Vidal R, Gatell JM.

AIDS. 2006 Jan 2;20(1):121-3.

http://catedrarecercaeugin.uab.cat/articles.asp